FDA Clears First Self-Balancing Personal Exoskeleton For People With Spinal Cord Injury

The U.S. Food and Drug Administration (FDA) has cleared Eve, a self-balancing personal exoskeleton for eligible wheelchair users with spinal cord injury. The device was developed by Wandercraft, which plans to commercially launch Eve in the United States on September 17, 2026. No pricing details were disclosed.

Eve is intended for eligible adults with spinal cord injury who can operate the device's remote control. The device allows users to walk and perform certain activities of daily living hands-free using self-balancing technology. It is intended for use on level indoor surfaces and adjacent outdoor areas under . . .